 <h1>Boniva Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ibandronate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ibandronate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Boniva.</p><h2>In Summary</h2><p><b>Common side effects of Boniva include:</b> bronchitis and arthralgia. <b>Other side effects include:</b> myalgia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ibandronate: oral tablet</i></p><p>Other dosage forms:</p><ul><li>intravenous solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ibandronate (the active ingredient contained in Boniva) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ibandronate:</p><p>
<i>More common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>chest pain</li>
<li>cough producing mucus</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>fever or chills</li>
<li>frequent urge to urinate</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>shortness of breath</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>tightness in the chest</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>congestion</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>dryness of the throat</li>
<li>fast heartbeat</li>
<li>frequent urge to urinate</li>
<li>hives</li>
<li>hoarseness</li>
<li>itching</li>
<li>numbness</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>runny nose</li>
<li>skin rash</li>
<li>tender, swollen glands in the neck</li>
<li>tingling</li>
<li>unusual tiredness or weakness</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>blurred vision or other change in vision</li>
<li>bone, joint, or muscle pain, severe and occasionally incapacitating</li>
<li>confusion</li>
<li>convulsions</li>
<li>eye redness</li>
<li>eye tenderness</li>
<li>heavy jaw feeling</li>
<li>irregular heartbeats</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loosening of a tooth</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>noisy breathing</li>
<li>numbness and tingling around the mouth, fingertips, or feet</li>
<li>pain, swelling, or numbness in the mouth or jaw</li>
<li>sensitivity to light</li>
<li>severe eye pain</li>
<li>tearing</li>
<li>tremor</li>
<li>unusual pain in the thighs, groin, or hips</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking ibandronate:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>bone pain</li>
<li>burning feeling in the chest or stomach</li>
<li>heartburn</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>pain or burning in the throat</li>
<li>sores or ulcers</li>
<li>stomach discomfort, upset, or pain</li>
<li>tenderness in the stomach area</li>
<li>vomiting</li>
<li>white spots on the lips or tongue or inside the mouth</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ibandronate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>ear congestion</li>
<li>headache</li>
<li>loss of voice</li>
<li>pain in the extremity (arms and legs)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Cough</li>
<li>difficulty having a bowel movement (stool)</li>
<li>difficulty with moving</li>
<li>discouragement</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling sad or empty</li>
<li>general feeling of discomfort or illness</li>
<li>irritability</li>
<li>joint pain</li>
<li>lack or loss of strength</li>
<li>lightheadedness</li>
<li>loss of interest or pleasure</li>
<li>muscle aches and pain</li>
<li>muscle stiffness</li>
<li>pain, swelling, or redness in the joints</li>
<li>sensation of spinning</li>
<li>shivering</li>
<li>stuffy nose</li>
<li>sweating</li>
<li>tooth disorder</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ibandronate: intravenous kit, intravenous solution, oral tablet</i></p><h3>General</h3><p>The most serious reported adverse reactions are anaphylactic reaction/shock, atypical fractures of the femur, osteonecrosis of the jaw, and ocular inflammation.</p>
<p></p>
<p>The most frequently reported adverse reactions are arthralgia and influenza-like symptoms, typically associated with the first dose, generally of short duration, mild, or moderate intensity.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, tooth disorder, vomiting, gastritis, constipation, gastroenteritis abdominal pain, esophagitis, nausea, sore throat</p>
<p><b>Uncommon</b> (0.1% to 1%): Hemorrhage, duodenal ulcer, dysphagia, dry mouth<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory infection (up to 34%)</p>
<p><b>Common</b> (1% to 10%): Bronchitis, pneumonia, pharyngitis, influenza, nasopharyngitis, asthma exacerbation</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Decreased renal calcium excretion may be accompanied by a fall in serum phosphate levels not requiring therapeutic measures.  The serum calcium level may fall to hypocalcemic values.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Hypocalcemia</p>
<p><b>Postmarketing reports</b>: Hypocalcemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (14%)</p>
<p><b>Common</b> (1% to 10%): Pain in the extremity, myalgia, joint disorder, arthritis, arthralgia, localized osteoarthritis, muscle cramp</p>
<p><b>Postmarketing reports</b>: Severe or incapacitating bone, join, or muscle pain (musculoskeletal pain); osteonecrosis of the jaw; atypical, low-energy, or low-trauma fractures of the femoral shaft; atypical subtrochanteric and diaphyseal femoral fractures<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Phlebitis, thrombophlebitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, cystitis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased gamma-glutamyl transpeptidase (GGT) levels<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p>
<p><b>Rare</b> (less than 0.1%): Facial swelling/edema, urticaria</p>
<p><b>Postmarketing reports</b>: Anaphylactic reaction/shock with fatalities, angioedema, bronchospasm, asthma exacerbations, rash, Stevens-Johnson syndrome, erythema multiforme, and dermatitis bullous<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Redness or swelling at the injection site<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, paraesthesia, dysgeusia (taste perversion)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, vertigo, influenza-like illness, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise, pain<sup>[Ref]</sup></p><p>Combination of influenza-like illness and acute phase reaction has occurred.  Influenza-like illness includes events reported as acute phase reaction or symptoms, including myalgia, arthralgia, fever, chills, fatigue, nausea, loss of appetite, and bone pain.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased creatinine</p>
<p><b>Uncommon</b> (0.1% to 1%): Azotemia (uremia)</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><p>Rash occurred in combination of rash pruritic, rash macular, rash papular, rash generalized, rash erythematous, dermatitis, dermatitis allergic, dermatitis medicamentosa, erythema and exanthema.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia, increased blood parathyroid hormone<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Postmarketing reports</b>: Ocular inflammation, iritis, uveitis, episcleritis (in some cases, these events resolve only after this drug was discontinued)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What medications are available to treat osteoporosis?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Boniva (ibandronate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>76 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: bisphosphonates</li>
<li>FDA Alerts (4)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Boniva &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Boniva Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Osteoporosis</li>
<li>Prevention of Osteoporosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ibandronate: intravenous kit, intravenous solution, oral tablet</i></p><h3>General</h3><p>The most serious reported adverse reactions are anaphylactic reaction/shock, atypical fractures of the femur, osteonecrosis of the jaw, and ocular inflammation.</p><p></p><p>The most frequently reported adverse reactions are arthralgia and influenza-like symptoms, typically associated with the first dose, generally of short duration, mild, or moderate intensity.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 12%)</p><p><b>Common</b> (1% to 10%): Diarrhea, tooth disorder, vomiting, gastritis, constipation, gastroenteritis abdominal pain, esophagitis, nausea, sore throat</p><p><b>Uncommon</b> (0.1% to 1%): Hemorrhage, duodenal ulcer, dysphagia, dry mouth<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory infection (up to 34%)</p><p><b>Common</b> (1% to 10%): Bronchitis, pneumonia, pharyngitis, influenza, nasopharyngitis, asthma exacerbation</p><p><b>Uncommon</b> (0.1% to 1%): Chest pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Decreased renal calcium excretion may be accompanied by a fall in serum phosphate levels not requiring therapeutic measures.  The serum calcium level may fall to hypocalcemic values.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Hypocalcemia</p><p><b>Postmarketing reports</b>: Hypocalcemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (14%)</p><p><b>Common</b> (1% to 10%): Pain in the extremity, myalgia, joint disorder, arthritis, arthralgia, localized osteoarthritis, muscle cramp</p><p><b>Postmarketing reports</b>: Severe or incapacitating bone, join, or muscle pain (musculoskeletal pain); osteonecrosis of the jaw; atypical, low-energy, or low-trauma fractures of the femoral shaft; atypical subtrochanteric and diaphyseal femoral fractures<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Phlebitis, thrombophlebitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, cystitis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased gamma-glutamyl transpeptidase (GGT) levels<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p><p><b>Rare</b> (less than 0.1%): Facial swelling/edema, urticaria</p><p><b>Postmarketing reports</b>: Anaphylactic reaction/shock with fatalities, angioedema, bronchospasm, asthma exacerbations, rash, Stevens-Johnson syndrome, erythema multiforme, and dermatitis bullous<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Redness or swelling at the injection site<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, paraesthesia, dysgeusia (taste perversion)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, vertigo, influenza-like illness, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Malaise, pain<sup>[Ref]</sup></p><p>Combination of influenza-like illness and acute phase reaction has occurred.  Influenza-like illness includes events reported as acute phase reaction or symptoms, including myalgia, arthralgia, fever, chills, fatigue, nausea, loss of appetite, and bone pain.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased creatinine</p><p><b>Uncommon</b> (0.1% to 1%): Azotemia (uremia)</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><p>Rash occurred in combination of rash pruritic, rash macular, rash papular, rash generalized, rash erythematous, dermatitis, dermatitis allergic, dermatitis medicamentosa, erythema and exanthema.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia, increased blood parathyroid hormone<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Postmarketing reports</b>: Ocular inflammation, iritis, uveitis, episcleritis (in some cases, these events resolve only after this drug was discontinued)<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What medications are available to treat osteoporosis?</li>
</ul><h2>More about Boniva (ibandronate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>76 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: bisphosphonates</li>
<li>FDA Alerts (4)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Boniva &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Boniva Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Osteoporosis</li>
<li>Prevention of Osteoporosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>